Cargando…
Adjuvant activity of Mycobacteria-derived mycolic acids
Successful vaccination, especially with safe vaccines such as component/subunit vaccines, requires proper activation of innate immunity and, for this purpose, adjuvant is used. For clinical use, alum is frequently used while, for experimental use, CFA, containing Mycobacterial components, was often...
Autores principales: | Kubota, Mio, Iizasa, Ei'ichi, Chuuma, Yasushi, Kiyohara, Hideyasu, Hara, Hiromitsu, Yoshida, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260583/ https://www.ncbi.nlm.nih.gov/pubmed/32490252 http://dx.doi.org/10.1016/j.heliyon.2020.e04064 |
Ejemplares similares
-
TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation
por: Iizasa, Ei’ichi, et al.
Publicado: (2021) -
Loss of CARD9-mediated innate activation attenuates severe influenza pneumonia without compromising host viral immunity
por: Uematsu, Takayuki, et al.
Publicado: (2015) -
MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria
por: Varela, Cristian, et al.
Publicado: (2012) -
Thiacetazone, an Antitubercular Drug that Inhibits Cyclopropanation of Cell Wall Mycolic Acids in Mycobacteria
por: Alahari, Anuradha, et al.
Publicado: (2007) -
Role of long-chain acyl-CoAs in the regulation of mycolic acid biosynthesis in mycobacteria
por: Tsai, Yi Ting, et al.
Publicado: (2017)